N-4-TOLUENESULFONYLUREIDO-N-[(5H-DIBENZO-[A,D]-CYCLOHEPTEN-5-YL)-METHYLEN]-GLYCINE
Compound with spectra: 1 NMR
![N-4-TOLUENESULFONYLUREIDO-N-[(5H-DIBENZO-[A,D]-CYCLOHEPTEN-5-YL)-METHYLEN]-GLYCINE](/api/compound/FtkheOeGP0h.png?ph=true&h=300&w=458 "N-4-TOLUENESULFONYLUREIDO-N-[(5H-DIBENZO-[A,D]-CYCLOHEPTEN-5-YL)-METHYLEN]-GLYCINE")
| SpectraBase Compound ID | FtkheOeGP0h |
|---|---|
| InChI | InChI=1S/C26H24N2O5S/c1-18-10-14-21(15-11-18)34(32,33)27-26(31)28(17-25(29)30)16-24-22-8-4-2-6-19(22)12-13-20-7-3-5-9-23(20)24/h2-15,24H,16-17H2,1H3,(H,27,31)(H,29,30) |
| InChIKey | MBJHIOBLSNHDBY-UHFFFAOYSA-N |
| Mol Weight | 476.55 g/mol |
| Molecular Formula | C26H24N2O5S |
| Exact Mass | 476.140593 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(2,3,7,8-tetramethoxy-5H-dibenzo[a,d]cyclohepten-5-ylmethyl)trimethylammonium methyl sulfate
SBAWNXPKVBCKLQ-UHFFFAOYSA-N
N-[2-(2-quinolon-5-yl)-2-phenyl-ethyl]N-methyl-acetamide
9,10-Dihydro-9,10-ethanoanthracene-1-carbonyl chloride
9,10-Dihydro-9,10-ethanoanthracene-11-carboxylic acid
4-(1-Benzyl-3-tosylureido)-2-(3-chlorophenyl)-2-oxazoline
N-(5-Phenyldibenzo[a,d]-5-cycloheptenyl)-N'-triphenylmethylurea
N,N'-Bis(5-phenyldibenzo[a,d]-5-cycloheptenyl)urea
4-Methyl-N-{tetracyclo[6.6.2.0(2,7).0(9,14)]hexadeca-2,4,6,9(14),10,12-hexaen-15-ylmethyl}benzamide
4,4-Dimethyl-2-[2'-[2"-(N-benzyl-N-methyl)amino-1''-phenylethyl]phenyl]oxazoline
| Title | Journal or Book | Year |
|---|---|---|
| Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating arylsulfonylureido and 5-dibenzo-suberenyl/suberyl moieties | Bioorganic & Medicinal Chemistry | 2003 |